Wei-syun S. Hu

2, Yuh Der Road
Taitung, TNQ 40447, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Pre-existing but not post-solid organ transplantation diabetes mellitus predicts end stage renal disease and mortality.

Pre-existing but not post-solid organ transplantation diabetes mellitus predicts end stage renal disease and mortality.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: May 05, 2025

Association of stroke and mortality among patients receiving heart transplantation-a nationwide study.

Association of stroke and mortality among patients receiving heart transplantation-a nationwide study.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 27, 2024

Hemorrhoid risk among people with diabetes mellitus using glucose lowering agents.

Hemorrhoid risk among people with diabetes mellitus using glucose lowering agents.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 27, 2024

Effect of traditional Chinese medicine on cardiovascular death and all-cause death among patients with heart failure and/or atrial fibrillation.

Effect of traditional Chinese medicine on cardiovascular death and all-cause death among patients with heart failure and/or atrial fibrillation.

Journal: Internal and emergency medicine

Published: June 19, 2024

Comparison of nebivolol, carvedilol, and bisoprolol for adverse clinical outcomes among patients with heart failure-a real-world nationwide investigation.

Comparison of nebivolol, carvedilol, and bisoprolol for adverse clinical outcomes among patients with heart failure-a real-world nationwide investigation.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 14, 2024

Impact of sacubitril/valsartan on adverse clinical events in heart failure with end-stage renal disease patients-a real life nationwide investigation.

Impact of sacubitril/valsartan on adverse clinical events in heart failure with end-stage renal disease patients-a real life nationwide investigation.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 11, 2024

Beneficial effect of sodium-glucose cotransporter-2 inhibitors on mortality among patients with cancer and diabetes mellitus.

Beneficial effect of sodium-glucose cotransporter-2 inhibitors on mortality among patients with cancer and diabetes mellitus.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 11, 2024

Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus.

Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 11, 2024

Psychiatric disorders in patients with type 2 diabetes mellitus on sodium-glucose cotransporter-2 inhibitors-a nationwide retrospective cohort study.

Psychiatric disorders in patients with type 2 diabetes mellitus on sodium-glucose cotransporter-2 inhibitors-a nationwide retrospective cohort study.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: May 10, 2023

Sodium-glucose cotransporter-2 inhibitor in risk of sepsis/septic shock among patients with type 2 diabetes mellitus-a retrospective analysis of nationwide medical claims data.

Sodium-glucose cotransporter-2 inhibitor in risk of sepsis/septic shock among patients with type 2 diabetes mellitus-a retrospective analysis of nationwide medical claims data.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: February 23, 2023

Diabetic patients with and without sodium-glucose cotransporter-2 inhibitors use and cataract risk: real-world observational investigation.

Diabetic patients with and without sodium-glucose cotransporter-2 inhibitors use and cataract risk: real-world observational investigation.

Journal: Acta diabetologica

Published: February 11, 2023

Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.

Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 30, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026